Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometryLIWEN ZHANG; FREITAS, Michael A; WICKHAM, Joseph et al.Journal of the American Society for Mass Spectrometry. 2004, Vol 15, Num 1, pp 77-86, issn 1044-0305, 10 p.Article

The MLL partial tandem duplication : evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapyWHITMAN, Susan P; SHUJUN LIU; BECKNELL, Brian et al.Blood. 2005, Vol 106, Num 1, pp 345-352, issn 0006-4971, 8 p.Article

Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemiaMARCUCCI, Guido; BYRD, John C; PORCU, Pierluigi et al.Blood. 2003, Vol 101, Num 2, pp 425-432, issn 0006-4971, 8 p.Article

Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia : Pharmacokinetics, pharmacodynamics, and clinical activityMARCUCCI, Guide; STOCK, Wendy; MORAN, Mollie et al.Journal of clinical oncology. 2005, Vol 23, Num 15, pp 3404-3411, issn 0732-183X, 8 p.Article